DK2044223T3 - Diagnosticering og behandling af aldersrelateret makuladegeneration - Google Patents
Diagnosticering og behandling af aldersrelateret makuladegenerationInfo
- Publication number
- DK2044223T3 DK2044223T3 DK07836260.5T DK07836260T DK2044223T3 DK 2044223 T3 DK2044223 T3 DK 2044223T3 DK 07836260 T DK07836260 T DK 07836260T DK 2044223 T3 DK2044223 T3 DK 2044223T3
- Authority
- DK
- Denmark
- Prior art keywords
- diagnosis
- age
- treatment
- macular degeneration
- related macular
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/172—Haplotypes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Ophthalmology & Optometry (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US83349706P | 2006-07-26 | 2006-07-26 | |
| US91940907P | 2007-03-22 | 2007-03-22 | |
| PCT/US2007/016809 WO2008013893A2 (en) | 2006-07-26 | 2007-07-26 | Diagnosis and treatment of age related macular degeneration |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2044223T3 true DK2044223T3 (da) | 2012-10-08 |
Family
ID=38982073
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK07836260.5T DK2044223T3 (da) | 2006-07-26 | 2007-07-26 | Diagnosticering og behandling af aldersrelateret makuladegeneration |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US20110052602A1 (da) |
| EP (1) | EP2044223B1 (da) |
| JP (1) | JP2009544317A (da) |
| AU (1) | AU2007277125B2 (da) |
| CA (1) | CA2658853A1 (da) |
| DK (1) | DK2044223T3 (da) |
| ES (1) | ES2391788T3 (da) |
| IL (1) | IL196016A (da) |
| MX (1) | MX2009000909A (da) |
| WO (1) | WO2008013893A2 (da) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6828097B1 (en) * | 2000-05-16 | 2004-12-07 | The Childrens Mercy Hospital | Single copy genomic hybridization probes and method of generating same |
| WO2008103299A2 (en) | 2007-02-16 | 2008-08-28 | Massachusetts Eye & Ear Infirmary | Methods and compositions for prognosing, detecting, and treating age-related macular degeneration |
| WO2009000520A1 (en) * | 2007-06-25 | 2008-12-31 | Universität Duisburg-Essen | Screening-method for polymorphic markers in htra1 gene in neurodegenerative disorders |
| TW200911290A (en) * | 2007-07-02 | 2009-03-16 | Alcon Res Ltd | RNAI-mediated inhibition of HTRA1 for treatment of macular degeneration |
| WO2009059321A2 (en) | 2007-11-01 | 2009-05-07 | University Of Iowa Research Foundation | Rca locus analysis to assess susceptibility to amd and mpgnii |
| WO2012125872A2 (en) * | 2011-03-15 | 2012-09-20 | University Of Utah Research Foundation | Methods of diagnosing and treating vascular associated maculopathy and symptoms thereof |
| JP6285929B2 (ja) * | 2012-07-17 | 2018-02-28 | カウンシル，インコーポレーテッド | 遺伝的変異を検出するためのシステムおよび方法 |
| EP2895624B1 (en) * | 2012-09-14 | 2022-06-01 | University Of Utah Research Foundation | Methods of predicting the development of amd based on chromosome 1 and chromosome 10 |
| US20180133328A1 (en) * | 2015-04-07 | 2018-05-17 | Universität Duisburg-Essen | Internalisation of human htra1 and cargo proteins into mammalian cells |
| DK3472149T3 (da) | 2016-06-21 | 2023-11-27 | Orion Ophthalmology LLC | Heterocykliske prolinamidderivater |
| JP7164521B2 (ja) | 2016-06-21 | 2022-11-01 | オリオン・オフサルモロジー・エルエルシー | 炭素環式プロリンアミド誘導体 |
| EP3478839A1 (en) | 2016-07-01 | 2019-05-08 | H. Hoffnabb-La Roche Ag | Antisense oligonucleotides for modulating htra1 expression |
| CA3047893C (en) * | 2016-12-22 | 2022-11-15 | Daiichi Sankyo Company, Limited | Spink2 peptide for preventing and/or treating age-related macular degeneration |
| US20190055564A1 (en) * | 2017-06-01 | 2019-02-21 | F. Hoffmann-La Roche Ag | Antisense oligonucleotides for modulating htra1 expression |
| CA3085211A1 (en) | 2017-12-21 | 2019-06-27 | F. Hoffmann-La Roche Ag | Companion diagnostic for htra1 rna antagonists |
| EP3768327A4 (en) * | 2018-03-23 | 2022-04-13 | The Trustees of Columbia University in the City of New York | GENE EDIT FOR AUTOSOMAL DOMINANT DISEASES |
| CN113966401A (zh) * | 2019-04-10 | 2022-01-21 | 犹他大学研究基金会 | 用于治疗amd的htra1调节 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040014097A1 (en) * | 2002-05-06 | 2004-01-22 | Mcglennen Ronald C. | Genetic test apparatus and method |
| US7351534B2 (en) * | 2003-01-27 | 2008-04-01 | Oregon Health & Sciences University | Gene mutation associated with age-related macular degeneration |
| CN102618644A (zh) * | 2004-11-18 | 2012-08-01 | 耶鲁大学 | 治疗眼病的方法和组合物 |
| JP2008529536A (ja) * | 2005-02-14 | 2008-08-07 | ユニバーシティー オブ アイオワ リサーチ ファウンデーション | 加齢性黄斑変性を処置および診断するための方法および試薬 |
| WO2006133295A2 (en) * | 2005-06-08 | 2006-12-14 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | SUSCEPTIBILITY GENES FOR AGE-RELATED MACULOPATHY (ARM) ON CHROMOSOME 10q26 |
| CN101331235A (zh) * | 2005-10-11 | 2008-12-24 | 耶鲁大学 | 与黄斑变性相关的基因 |
| SG173371A1 (en) * | 2006-07-13 | 2011-08-29 | Univ Iowa Res Found | Methods and reagents for treatment and diagnosis of vascular disorders and age-related macular degeneration |
-
2007
- 2007-07-26 EP EP07836260A patent/EP2044223B1/en not_active Not-in-force
- 2007-07-26 ES ES07836260T patent/ES2391788T3/es active Active
- 2007-07-26 AU AU2007277125A patent/AU2007277125B2/en not_active Ceased
- 2007-07-26 JP JP2009521835A patent/JP2009544317A/ja not_active Withdrawn
- 2007-07-26 WO PCT/US2007/016809 patent/WO2008013893A2/en active Application Filing
- 2007-07-26 MX MX2009000909A patent/MX2009000909A/es active IP Right Grant
- 2007-07-26 DK DK07836260.5T patent/DK2044223T3/da active
- 2007-07-26 CA CA002658853A patent/CA2658853A1/en not_active Abandoned
- 2007-07-26 US US12/309,616 patent/US20110052602A1/en not_active Abandoned
-
2008
- 2008-12-17 IL IL196016A patent/IL196016A/en active IP Right Grant
-
2014
- 2014-09-29 US US14/499,963 patent/US20150152500A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CA2658853A1 (en) | 2008-01-31 |
| WO2008013893A3 (en) | 2008-05-29 |
| WO2008013893A2 (en) | 2008-01-31 |
| IL196016A (en) | 2013-03-24 |
| EP2044223A2 (en) | 2009-04-08 |
| US20150152500A1 (en) | 2015-06-04 |
| MX2009000909A (es) | 2009-02-04 |
| AU2007277125A1 (en) | 2008-01-31 |
| ES2391788T3 (es) | 2012-11-29 |
| IL196016A0 (en) | 2009-09-01 |
| JP2009544317A (ja) | 2009-12-17 |
| EP2044223B1 (en) | 2012-06-27 |
| AU2007277125B2 (en) | 2013-08-01 |
| US20110052602A1 (en) | 2011-03-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK2044223T3 (da) | Diagnosticering og behandling af aldersrelateret makuladegeneration | |
| BRPI0811007A2 (pt) | Tratamento de degeneração macular relacionada à idade usando inibidores de fator de complemento d | |
| DK3067066T3 (da) | Forebyggelse og behandling af synukleinopatisk og amyloidogenisk sygdom | |
| DK2245199T3 (da) | Anvendelse af mikrovesikler i diagnosticering, prognosticering og behandling af medicinske sygdomme og tilstande | |
| DK2350416T4 (da) | Multipel rude med mindst én antirefleksbehandling og anvendelse af antirefleksbehandling i multipel rude | |
| DK1853271T3 (da) | Fremgangsmåde og præparat til behandling af perifere vaskulære sygdomme | |
| ATE531720T1 (de) | Aza-benzofuranylverbindungen und anwendungsverfahren dafür | |
| DK2796469T3 (da) | Hidtil ukendte sammensætninger og fremgangsmåder til behandling af IgE-medierede forstyrrelser | |
| IL220723A0 (en) | Compositions of humanized notch fusion proteins and methods of treatment | |
| ZA201005922B (en) | Method of treatment of age-related macular degeneration (amd) | |
| DK1917246T3 (da) | Benzoquinazolinderivater og deres anvendelse til behandling af knoglesygdomme | |
| DK1986633T3 (da) | Behandling af duchennes muskeldystrofi | |
| BRPI0818725A2 (pt) | implantes espinhais e métodos | |
| DK2114447T3 (da) | Forebyggelse og behandling af subkliniks pcvd | |
| DK2056807T3 (da) | Behandling af inflammatoriske sygdomme | |
| DK2004204T3 (da) | Behandling af neurodegenerative sygdomme med selenat | |
| BRPI0716466A2 (pt) | Tratamento da calda de açúcar | |
| DK2187880T3 (da) | Sammensætninger og fremgangsmåder til behandling af makuladegeneration | |
| DK1962869T3 (da) | Behandling af luftvejssygdomme | |
| BRPI0815551A2 (pt) | Tratamento através de hucbc de doença beta-amiloide | |
| DK2297106T3 (da) | Phenoxypyridinylamidderivater og deres anvendelse til behandling af pde4-medierede sygdomstilstande | |
| PL2252317T3 (pl) | Leczenie zwyrodnienia plamki żółtej | |
| FI20060995A0 (fi) | Luonnollisen kielen käsittely | |
| ZA200806808B (en) | Treatment of stressed patients | |
| DK1919290T3 (da) | Fremgangsmåder og produkter til behandling af sygdomme |